Mycoplasma Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
In conclusion we have shown that P36 is a protein that is a common antigen of M. hyopneumoniae strains and is not found in other Mycoplasma or Acholeplasma species tested.
|
1723490 |
1991 |
Liver carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
A 960-base-pair cDNA was isolated and found to be a partial cDNA encoding the human protein-tyrosine kinase substrate p36, also known as lipocortin II. p36 expression was highly abundant in hepatocellular carcinomas at both the transcript and protein levels.
|
2160596 |
1990 |
Malignant transformation
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
We report here the initial description of the association of increased p36 expression with malignant transformation.
|
2160596 |
1990 |
Liver carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
These investigations explored the effect of ethanol additions on the expression and tyrosyl phosphorylation (TP) of p36 and IRS-1 in a human hepatocellular carcinoma cell line (FOCUS) in relationship to cell proliferation induced by IN and serum growth factor stimulation.
|
7542850 |
1995 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Central neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Childhood Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Neuroectodermal Tumor, Primitive
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Instead, p36 gene expression was modulated in both proliferating and non-proliferating PNET cell cultures by treatment with 50 mIU/ml of insulin, 100 mM ethanol, or 5 microM retinoic acid.
|
7738588 |
1995 |
Lupus Vulgaris
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Lupus Erythematosus, Discoid
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Lupus Erythematosus, Systemic
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Lupus Erythematosus
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results show that p36 is a new interferon-alpha-induced protein that localizes in the endoplasmic reticulum, the cell region in which the lupus inclusions form, and that p36 is probably physically associated with the lupus inclusions.
|
8557639 |
1996 |
Leprosy
|
0.010 |
Biomarker
|
disease |
BEFREE |
All seven sarcoidosis, four of six tuberculosis, and all six leprosy patient serum specimens showed strong reactivity with p36 antigen.
|
8862592 |
1996 |
Mycobacterium Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, the reactivity of antibodies in sarcoid patient sera against p36 and PTB65K antigens was comparable to the reactivity of sera obtained from patients with known mycobacterial disease.
|
8862592 |
1996 |
Sarcoidosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In contrast, 13 of 38 controls showed only weak reactivity with p36 (P = 0.002 for controls versus sarcoidosis samples).
|
8862592 |
1996 |
Bare Lymphocyte Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Both the p41 and p36 subunits were absent in immunoprecipitations of RFX5 from lysates of independently established B cell lines from bare lymphocyte syndrome complementation groups B and D. Together, these results suggest that RFX complex assembly is required for class II expression and that the mutations in bare lymphocyte syndrome complementation groups B and D result in an inability to assemble the RFX complex.
|
9190936 |
1997 |
Bare lymphocyte syndrome 2
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Both the p41 and p36 subunits were absent in immunoprecipitations of RFX5 from lysates of independently established B cell lines from bare lymphocyte syndrome complementation groups B and D. Together, these results suggest that RFX complex assembly is required for class II expression and that the mutations in bare lymphocyte syndrome complementation groups B and D result in an inability to assemble the RFX complex.
|
9190936 |
1997 |
Crohn Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
The fact that sera from Crohn's disease patients reacted to p36 with the same high frequency as the sera from patients that were exposed to mycobacterial antigens further supports the hypothesis of the mycobacterial etiology in Crohn's disease.
|
10398839 |
1999 |
Paratuberculosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease.
|
10398839 |
1999 |
Ulcerative Colitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Sera from 77 of 89 (86.5%) Crohn's disease patients and 16 of 18 (89%) sera from patients with tuberculosis and leprosy reacted with p36 compared to 5 of 42 (12%) ulcerative colitis and non-IBD control sera (p < 0.0001).
|
10398839 |
1999 |
Inflammatory Bowel Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Sera from 77 of 89 (86.5%) Crohn's disease patients and 16 of 18 (89%) sera from patients with tuberculosis and leprosy reacted with p36 compared to 5 of 42 (12%) ulcerative colitis and non-IBD control sera (p < 0.0001).
|
10398839 |
1999 |
Tuberculosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Sera from 77 of 89 (86.5%) Crohn's disease patients and 16 of 18 (89%) sera from patients with tuberculosis and leprosy reacted with p36 compared to 5 of 42 (12%) ulcerative colitis and non-IBD control sera (p < 0.0001).
|
10398839 |
1999 |
Diabetes
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition to the documented effect of diabetes to increase p36 mRNA and protein in the liver and kidney, a approximately 2-fold increase in the mRNA abundance of p46 was found in liver, kidney, and intestine, and a similar increase was found in the p46 protein level in liver.
|
10567346 |
1999 |
Diabetes Mellitus
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In addition to the documented effect of diabetes to increase p36 mRNA and protein in the liver and kidney, a approximately 2-fold increase in the mRNA abundance of p46 was found in liver, kidney, and intestine, and a similar increase was found in the p46 protein level in liver.
|
10567346 |
1999 |